FDA clears new esophageal temperature probe for US sale
Click Here to Manage Email Alerts
Circa Scientific announced it received FDA clearance for U.S. sale of its esophageal temperature probe.
According to a company release, the new probe (S-CATH M) provides edge-to-edge coverage of the esophagus and can be visualized on 3D cardiac mapping systems, potentially reducing physician dependence on fluoroscopy and decreasing radiation exposure.
“We designed S-CATH M to support physicians’ efforts to minimize the amount of radiation their patients and staff are exposed to during their procedures without compromising on the features that set our portfolio of products apart” Lee Geist, president and CEO of Circa Scientific, said in the release.
Four electrodes down the centerline of the new probe allow it to be placed, positioned and visualized on 3D mapping, according to the release. The probe is also designed to limit the amount of exposed metal to only what is absolutely necessary to be detected on 3D cardiac mapping systems and minimize risk for radiofrequency interaction.
Collapse
Read more about
Click Here to Manage Email Alerts